News | Radiation Therapy | March 31, 2021

ASTRO Survey Finds Pandemic Has Led to More Advanced-stage Cancer Diagnoses

The National Comprehensive Cancer Network® (NCCN®) and the American Cancer Society (ACS) are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

March 31, 2021 — Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced disease than before the COVID-19 pandemic, according to a new survey from the American Society for Radiation Oncology (ASTRO). The national survey of radiation therapy practice leaders fielded this winter also indicates that treatment postponements and deferrals that were common a year ago have largely subsided and that clinics continue to use a variety of enhanced safety measures to protect their patients and staff.

"One year into the COVID-19 pandemic, we already see the consequences of pandemic-driven drops in cancer screening and diagnostics," said Thomas J. Eichler, M.D., FASTRO, Chair of the ASTRO Board of Directors.

Two-thirds of the radiation oncologists (66%) said new patients are presenting with more advanced-stage cancers. Nearly three-fourths (73%) said physicians in their practice are noticing that patients are not receiving cancer screenings, and many also said existing patients experienced an interruption in their radiation treatment due to the pandemic (66%).

"Because the pandemic and cancer cause disproportionately more harm for Black and other medically underserved populations, these rates may be even higher for some vulnerable communities," added Eichler.

Enhanced safety protocols remain widespread at radiation therapy clinics. Masking for patients and staff (99%), social distancing in the clinic (100%) and screening patients and staff for COVID-19 exposure (95%) are nearly universal. Increased sterilization (93%), face shields for staff during procedures (80%) and no-visitor policies (73%) are also common.

"Safety is at the core of radiation oncology, and clinics were ready to adapt quickly and ramp up protective measures that keep their staff and patients safe from COVID-19 exposure," said Eichler.

The survey also found that clinics have largely stopped deferring or postponing radiation treatments. Only 15% reported postponing treatment in January/February 2021, compared to 92% in April 2020. Similarly, 12% reported deferring any new patient visits in 2021, compared to 75% in the early weeks of the pandemic.

Four in 10 practices still reported difficulty accessing personal protective equipment, medical-grade hand sanitizer or other critical supplies in the initial months of 2021. More alarmingly, many physicians said that COVID-19 vaccination efforts at their practice were limited by access to the vaccine (53%), and by hesitation to receive the vaccine among staff (59%) and patients (52%). The high rates of hesitancy echo findings that more than half of frontline health care workers in the U.S. were unvaccinated as of early March 2021.

ASTRO recently joined a coalition led by the American Cancer Society and National Comprehensive Cancer Network to encourage the American public to resume cancer screening and treatment, emphasizing that cancer won't wait until the pandemic ends. ASTRO also updated its COVID-19 clinical guidance to include support for COVID-19 vaccination for people receiving radiation therapy, as long as the individual does not have increased risk of a reaction to the vaccine. Patients are encouraged to consult with their radiation oncologist regarding timing and location of the injection.

Additional Survey Findings

The pandemic is not affecting clinics equally. Radiation oncologists at community-based private practices were more likely to report seeing advanced-stage cancers among their patients, compared to those at university-affiliated clinics. PPE shortages and pandemic-related treatment interruptions were also more common at private practices. Differences emerged regarding the COVID-19 vaccine, as well. Both vaccine access and vaccine hesitation were more problematic barriers for clinics located outside of major metropolitan areas (i.e., population <1 million) and for community-based private practices, compared to university-affiliated clinics.

Telemedicine remains popular. More than 8 in 10 clinics (85%) offer telemedicine options for follow-up surveillance visits, and more than half (54%) do so for new patient consultations. Fewer clinics (15%) use telemedicine for clinician assessments of patients who are undergoing radiation treatments.

Radiation therapy clinics continue to face financial and operational challenges created by the pandemic. Patient volume dropped at 73% of clinics due to the COVID-19 pandemic, and visits were down 21%, on average. Most practices (72%) reduced staff at some point due to the COVID-19 pandemic.

Clinics have stayed open, however. One hundred percent of the physicians surveyed said their radiation therapy networks remained open during multiple spikes of the pandemic. Just 7% closed any satellite locations.

Survey Methodology

An online survey was sent by email to 509 radiation oncologists identified in ASTRO’s member database as medical directors of U.S. based radiation oncology practices, and 117 physicians completed the survey online January 15 through February 7, 2021 (23% response rate). For more information about respondent demographics, view the survey report.

For more information:

Related Content

Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

Diagram showing details of the lung screening experiment. Image courtesy of the European Respiratory Society/Benoit Audelan

News | Artificial Intelligence | September 08, 2021
September 8, 2021 — An artificial intell...
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.